Isothermal Nucleic Acid Amplification Technology/INAAT Market

Isothermal Nucleic Acid Amplification Technology/INAAT Market by Product (Assay & Kit, System), Application (Infectious disease [HIV, Influenza], Blood Screening), Type (LAMP, SDA, NASBA, HDA), End User, Region - Global Forecast to 2024

Report Code: BT 2491 Jan, 2020, by marketsandmarkets.com
COVID-19

Get in-depth analysis of the COVID-19 impact on the Isothermal Nucleic Acid Amplification Technology/INAAT Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Isothermal Nucleic Acid Amplification Technology/INAAT Market

Request For Special Pricing

[140 Pages Report] The global isothermal nucleic acid amplification technology (INAAT) market size is projected to reach USD 3.3 billion in 2024 from USD 1.9 billion in 2019, at a CAGR of 11.0% during the forecast period. Market growth is driven mainly by factors such as the rising prevalence of infectious diseases and the introduction of newer pathogens, the need for prompt diagnosis, the increasing number of blood transfusions and donations, and the cost-benefits of INAAT. However, the extensive usage and reliance on PCR is a major factor restraining the growth of the INAAT market during the forecast period.

Isothermal Nucleic Acid Amplification Technologies Market, INAAT Market

By product, assay, kits and reagents segment is expected to grow at the highest CAGR during the forecast period

Based on product, the market is segmented broadly into assay, kits and reagents and systems. The assay, kits and reagents segment is projected to grow at the highest CAGR during the forecast period because of increasing number of infectious disease diagnostic tests carried out; the increasing prevalence of infectious diseases; the continuous launch of newer, faster, and more reliable POC products; increasing approvals of CLIA-waived tests; accessibility to a wide range of reagents; repeated purchase of reagents; and the increasing use of reagents in therapeutics, basic research, and assay development.

By type, the transcription-mediated amplification segment is expected to witness the highest growth in the INAAT market during the forecast period.

Transcription mediated amplification segment is expected to show the highest growth in the forecast period. The large share of this segment is attributed to the growing reliance on POC diagnosis in hospitals and blood banks.

By application, the infectious disease diagnosis segment is expected to witness the highest growth in the INAAT market during the forecast period.

Infectious disease diagnosis is expected to show the highest growth in the forecast period owing to the increasing number of infectious disease diagnostic tests carried out and the rising prevalence of infectious diseases, among others.

By end-users, the hospital segment is growing at the highest CAGR during the forecast period.

The hospital segment is projected to register the highest growth rate during the forecast period because hospitals are equipped with fully automated INAAT instruments and offer test results quickly as compared to reference laboratories. Owing to these factors, the market for INAAT systems and consumables in hospitals is larger than the other end-user segments.

Isothermal Nucleic Acid Amplification Technologies Market, INAAT Market

North America is expected to account for the largest market share during the forecast period.

The INAAT market is divided into four major regions- Europe, North America, Asia Pacific, and the Rest of the World (RoW). In 2018, North America accounted for the largest share of the global market, closely followed by Europe. Factors such as the presence of a well-established healthcare system, access to technologically advanced diagnostics and blood screening techniques, recommendations for blood screening, high and growing burden of infectious diseases, rising number of genome-based drug development activities, and the availability of R&D funding for genomics research are the major factors that are expected to drive the growth of the North American market during the forecast period.

Asia Pacific is estimated to grow at the highest CAGR during the forecast period. Factors such as the sustained economic growth in several Asia Pacific countries, the rising disposable income, healthcare infrastructure modernization, increasing penetration of cutting-edge diagnostic technologies (including INAAT) for research and clinical applications, high infectious disease burden, availability of low-cost POC INAAT assays, and growing awareness among physicians and healthcare professionals about the benefits of gene-based disease diagnosis and treatment in Asia Pacific countries are expected to support market growth in this region during the forecast period.

Key Market Players

The major companies in the INAAT market include Grifols S.A. (Spain), Hologic, Inc. (US), Abbott Laboratories, Inc. (US), Becton, Dickinson & Company (US), and Meridian Bioscience (US).

Grifols S.A.  (Spain) held the leading position in this market primarily due to its strong portfolio of INAAT assays and systems for blood screening applications. In addition, the company has strengthened its market position through the expansion of its product portfolio. Grifols has a strong presence in the US and Canada and is focusing on penetrating emerging economies. For instance, in September 2016, the company opened a new training center in Dubai to support its Diagnostic business in the Middle East and Africa and further strengthen its market position.

Scope of the Report

Report Metric

Details

Market size available for years

2017–2024

Base year considered

2018

Forecast period

2019–2024

Forecast units

Values (USD Million/Billion)

Segments covered

Product, Type, Application, End User, and Region

Geographies covered

North America (US, Canada), Europe (Germany, UK, France, ROE), APAC , and RoW

Top Companies covered

Becton, Dickinson & Company (US), Hologic, Inc. (US), Grifols, S.A. (Spain), EIKEN CHEMICAL CO., LTD. (Japan), Meridian Bioscience (US), Quidel Corporation (US), QIAGEN (Netherlands), bioMιrieux SA (France), Tecan Trading AG (Switzerland), DiaSorin S.p.A.(Italy), Abbott Laboratories, Inc. (US), Thermo Fisher Scientific, Inc. (US), GE Healthcare (US), Illumina, Inc. (US), New England Biolabs, Inc. (US), TwistDx Limited (US), Mast Group Ltd. (UK), Lucigen Corporation (US), Ustar Biotechnologies Ltd. (China), Genomtec SA (Poland), Jena Bioscience GmbH (Germany), OptiGene Limited (UK), Sysmex Corporation (Japan), PREMIER Biosoft (US), and mFluiDx (US).

Based on the product:

  • Assay, Kits and Reagents
  • Systems

Based on the type:

  • TMA
  • LAMP
  • SDA
  • HDA
  • NASBA
  • Other Technologies (recombinase polymerase amplification (RPA), single-primer isothermal amplification (SPIA), signal-mediated amplification of RNA technology (SMART), rolling circle amplification (RCA), cross-priming amplification (CPA), circular helicase-dependent amplification (cHDA), nicking enzyme amplification reaction (NEAR), and multiple displacement amplification (MDA)

Based on the application:

  • Infectious Disease Diagnosis
    • Hepatitis
    • CT/NG
    • HIV
    • Influenza
    • Other Infectious Disease (hospital acquired infections (HAIs), tuberculosis, HPV, streptococcus, malaria, Zika, dengue, West Nile virus, respiratory syncytial virus, pneumonia, trichomonas vaginalis, genital mycoplasma, herpes simplex virus, pertussis, Bordetella, norovirus, and rotavirus)
  • Blood Screening
  • Other Applications (cancer diagnosis, cancer research, and laboratory research, which encompass cDNA preparation, whole-genome amplification (WGA), single-nucleotide polymorphism (SNP), and mutation analysis)

Based on end user:

  • Hospital
  • Reference Laboratories
  • Academic and Research Institutes
  • Other end user (physicians’ offices and clinics, blood banks, donor banks, community clinic laboratories, and IVD manufacturers. Physicians’ offices and clinics, blood banks, donor banks, and community clinic laboratories)

Based on the region:

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • RoE
  • Asia Pacific
  • RoW

Recent Developments:

  • In 2019, Hologic (US) launched Aptima BV and Aptima CV/TV Assays
  • In 2018, Grifols (Spain) ) launched Procleix Babesia assay
  • In 2018, Tecan Trading AG (Switzerland) acquired Nugen Technologies (US) which helped the company to enhance its next-generation sequencing reagents portfolio. This development helped the company to accelerate its broad genomics strategy.
  • In 2016, Eiken Chemicals (Japan) signed a distribution agreement with HUMAN (Germany), for distribution of loop-mediated isothermal amplification-based tuberculosis and malaria molecular diagnostic systems in the global market (except in Japan, China, Korea, Taiwan, and Thailand).

Key questions addressed by the report:

  • Who are the major market players in the INAAT market?
  • What are the regional growth trends and the largest revenue-generating regions INAAT market?
  • What are the major drivers and challenges in the INAAT market?
  • What are the major product segments in the INAAT market?
  • What are the major end-users for the INAAT?

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 13)
    1.1 Objectives of the Study
    1.2 Market Definition
           1.2.1 Inclusions and Exclusions
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 18)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Secondary Sources
           2.1.2 Primary Data
    2.2 Market Estimation Methodology
           2.2.1 Disease-Based Market Estimation Approach
           2.2.2 MnM-Know Approach
           2.2.3 Application-Based Market Estimation Approach
           2.2.4 Primary Research Validation
    2.3 Data Triangulation
    2.4 Research Assumptions

3 Executive Summary (Page No. - 26)

4 Premium Insights (Page No. - 31)
    4.1 Isothermal Nucleic Acid Amplification Technology Market Overview
    4.2 North America: Isothermal Nucleic Acid Amplification Technology Market Share, By Product & Country (2019)
    4.3 Isothermal Nucleic Acid Amplification Technology Market, By End User
    4.4 Isothermal Nucleic Acid Amplification Technology Market, By Application
    4.5 Isothermal Nucleic Acid Amplification Technology Market, By Type

5 Market Overview (Page No. - 35)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Rising Prevalence of Infectious Diseases and the Introduction of Newer Pathogens
                    5.2.1.2 Need for Prompt Diagnosis and Rapid Treatment
                    5.2.1.3 Increasing Blood Transfusion and Donations
                    5.2.1.4 Cost-Benefits
           5.2.2 Restraint
                    5.2.2.1 Dominance of Pcr
           5.2.3 Opportunities
                    5.2.3.1 Technology Optimization and Development
                    5.2.3.2 Emerging Economies

6 Isothermal Nucleic Acid Amplification Technology Market, By Product (Page No. - 39)
    6.1 Introduction
    6.2 Assays, Kits, and Reagents
           6.2.1 Assays, Kits, & Reagents Accounted for the Largest Share of the Market in 2018
    6.3 Systems
           6.3.1 Market for Systems to Witness Steady Growth Due to Moderate Requirement in Hospitals and Clinical Laboratories

7 Isothermal Nucleic Acid Amplification Technology Market, By Type (Page No. - 44)
    7.1 Introduction
    7.2 Transcription-Mediated Amplification
           7.2.1 Tma Accounts for the Largest Share of the Market
    7.3 Loop-Mediated Isothermal Amplification
           7.3.1 Rapidity, Stability, and Sensitivity Have Driven the Use of Lamp
    7.4 Strand Displacement Amplification
           7.4.1 Mirna Amplification for Cancer Diagnosis is the Major Application of Sda
    7.5 Helicase-Dependent Amplification
           7.5.1 Compatibility With Microfluidic Technologies & Development of Lab-On-Chip Devices Support Market Growth in Hda
    7.6 Nucleic Acid Sequence-Based Amplification
           7.6.1 Advantages of Nasba Over Pcr has Enhanced Its Adoption in Clinical Settings
    7.7 Other Technologies

8 Isothermal Nucleic Acid Amplification Technology Market, By Application (Page No. - 54)
    8.1 Introduction
    8.2 Infectious Disease Diagnosis
           8.2.1 Hepatitis
                    8.2.1.1 Need to Combat the High Prevalence of Hepatitis has Raised the Demand for INAAT Assays
           8.2.2 Ct/Ng
                    8.2.2.1 Adoption of INAAT for Ct/Ng Diagnosis is Growing Owing to Its Advantages Over Traditional Diagnostic Techniques
           8.2.3 Hiv
                    8.2.3.1 New Product Development Will Provide Considerable Potential for Growth in the Near Future
           8.2.4 Influenza
                    8.2.4.1 Nasba, Lamp, and Samba are Considered Highly Efficient and Reliable Methods of Influenza Diagnosis
           8.2.5 Other Infectious Diseases
    8.3 Blood Screening
           8.3.1 Increasing Number of Blood Donations and Transfusions Have Driven the Use of INAAT in Blood Screening Applications
    8.4 Other Applications

9 Isothermal Nucleic Acid Amplification Technology Market, By End User (Page No. - 67)
    9.1 Introduction
    9.2 Hospitals
           9.2.1 Hospitals Formed the Largest End-User Segment in the INAAT Market in 2018
    9.3 Reference Laboratories
           9.3.1 Outsourcing of Tests From Small Hospitals, Physicians’ Offices, and Clinics to Support the Growth of This End-User Segment
    9.4 Academic & Research Institutes
           9.4.1 Industry-Academia Collaborations Supporting the Adoption of INAAT
    9.5 Other End Users

10 Isothermal Nucleic Acid Amplification Technology Market, By Region (Page No. - 74)
     10.1 Introduction
     10.2 North America
             10.2.1 US
                        10.2.1.1 US is A Well-Developed Market for Genome Analysis Techniques
             10.2.2 Canada
                        10.2.2.1 Investments for Genomic Research and Development of Diagnostics are Supporting Market Growth in Canada
     10.3 Europe
             10.3.1 Germany
                        10.3.1.1 Germany Dominated the European INAAT Market in 2018
             10.3.2 France
                        10.3.2.1 Supportive Government Policies That Aim to Ease Public Access to Diagnostic Assay Procedures to Drive Growth in the INAAT Market
             10.3.3 UK
                        10.3.3.1 Adoption of INAAT Products is Expected to Increase in the UK as A Result of the Growing Focus of Public and Private Organizations on Genomics Research
             10.3.4 RoE
     10.4 Asia Pacific
             10.4.1 Asia Pacific to Offer Significant Growth Opportunities for INAAT Market Players
     10.5 RoW
             10.5.1 The RoW INAAT Market is Significantly Smaller Than Other Markets

11 Competitive Landscape (Page No. - 99)
     11.1 Introduction
     11.2 Market Ranking Analysis, 2018
     11.3 Competitive Leadership Mapping
             11.3.1 Visionary Leaders
             11.3.2 Innovators
             11.3.3 Dynamic Differentiators
             11.3.4 Emerging Companies
     11.4 Competitive Scenario
             11.4.1 Key Product Launches
             11.4.2 Key Acquisitions
             11.4.3 Key Partnerships, Agreements, Contracts, and Collaborations
             11.4.4 Key Expansions

12 Company Profiles (Page No. - 103)
     12.1 Grifols, S.A.
             12.1.1 Business Overview
             12.1.2 Products Offered
             12.1.3 Recent Developments
             12.1.4 MnM View
     12.2 Hologic, Inc.
             12.2.1 Business Overview
             12.2.2 Products Offered
             12.2.3 Recent Developments
             12.2.4 MnM View
     12.3 Abbott Laboratories, Inc.
             12.3.1 Business Overview
             12.3.2 Products Offered
             12.3.3 Recent Developments
             12.3.4 MnM View
     12.4 Becton, Dickinson and Company
             12.4.1 Business Overview
             12.4.2 Products Offered
     12.5 Meridian Bioscience
             12.5.1 Business Overview
             12.5.2 Products Offered
             12.5.3 Recent Developments
     12.6 EIKEN CHEMICALS Co., Ltd.
             12.6.1 Business Overview
             12.6.2 Products Offered
             12.6.3 Recent Developments
     12.7 Quidel Corporation
             12.7.1 Business Overview
             12.7.2 Products Offered
             12.7.3 Recent Developments
     12.8 Tecan Trading AG
             12.8.1 Business Overview
             12.8.2 Products Offered
             12.8.3 Recent Developments
     12.9 Diasorin Group S.P.A
             12.9.1 Business Overview
             12.9.2 Products Offered
     12.10 Qiagen
             12.10.1 Business Overview
             12.10.2 Products Offered
     12.11 Illumina, Inc.
             12.11.1 Business Overview
             12.11.2 Products Offered
     12.12 Thermo Fisher Scientific, Inc.
             12.12.1 Business Overview
             12.12.2 Products Offered
     12.13 Biomιrieux SA
             12.13.1 Business Overview
             12.13.2 Products Offered
     12.14 GE Healthcare
             12.14.1 Business Overview
             12.14.2 Products Offered
     12.15 Other Companies
             12.15.1 New England Biolabs, Inc.
             12.15.2 Lucigen Corporation
             12.15.3 Ustar Biotechnologies Ltd.
             12.15.4 TwistDx Limited
             12.15.5 Mast Group Ltd.
             12.15.6 Genomtec SA

13 Appendix (Page No. - 134)
     13.1 Discussion Guide
     13.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     13.3 Available Customizations
     13.4 Related Reports
     13.5 Author Details


List of Tables (109 Tables)

Table 1 Isothermal Nucleic Acid Amplification Technology Market, By Product, 2017–2024 (USD Million)
Table 2 INAAT Assays, Kits, & Reagents Market, By Region, 2017–2024 (USD Million)
Table 3 North America: INAAT Assays, Kits, & Reagents Market, By Country, 2017–2024 (USD Million)
Table 4 Europe: INAAT Assays, Kits, & Reagents Market, By Country, 2017–2024 (USD Million)
Table 5 INAAT Systems Market, By Region, 2017–2024 (USD Million)
Table 6 North America: INAAT Systems Market, By Country, 2017–2024 (USD Million)
Table 7 Europe: INAAT Systems Market, By Country, 2017–2024 (USD Million)
Table 8 INAAT Market, By Type, 2017–2024 (USD Million)
Table 9 INAAT Market for Tma, By Region, 2017–2024 (USD Million)
Table 10 North America: INAAT Market for Tma, By Country, 2017–2024 (USD Million)
Table 11 Europe: INAAT Market for Tma, By Country, 2017–2024 (USD Million)
Table 12 INAAT Market for Lamp, By Region, 2017–2024 (USD Million)
Table 13 North America: INAAT Market for Lamp, By Country, 2017–2024 (USD Million)
Table 14 Europe: INAAT Market for Lamp, By Country, 2017–2024 (USD Million)
Table 15 INAAT Market for Sda, By Region, 2017–2024 (USD Million)
Table 16 North America: INAAT Market for Sda, By Country, 2017–2024 (USD Million)
Table 17 Europe: INAAT Market for Sda, By Country, 2017–2024 (USD Million)
Table 18 INAAT Market for Hda, By Region, 2017–2024 (USD Million)
Table 19 North America: INAAT Market for Hda, By Country, 2017–2024 (USD Million)
Table 20 Europe: INAAT Market for Hda, 2017–2024 (USD Million)
Table 21 INAAT Market for Nasba, By Region, 2017–2024 (USD Million)
Table 22 North America: INAAT Market for Nasba, By Country, 2017–2024 (USD Million)
Table 23 Europe: INAAT Market for Nasba, By Country, 2017–2024 (USD Million)
Table 24 INAAT Market for Other Technologies, By Region, 2017–2024 (USD Million)
Table 25 North America: INAAT Market for Other Technologies, By Country, 2017–2024 (USD Million)
Table 26 Europe: INAAT Market for Other Technologies, By Country, 2017–2024 (USD Million)
Table 27 INAAT Market, By Application, 2017–2024 (USD Million)
Table 28 INAAT Market for Infectious Disease Diagnosis, By Region, 2017–2024 (USD Million)
Table 29 North America: INAAT Market for Infectious Disease Diagnosis, By Country, 2017–2024 (USD Million)
Table 30 Europe: INAAT Market for Infectious Disease Diagnosis, By Country, 2017–2024 (USD Million)
Table 31 INAAT Market for Infectious Disease Diagnosis, By Disease Type, 2017–2024 (USD Million)
Table 32 INAAT Market for Hepatitis Diagnosis, By Region, 2017–2024 (USD Million)
Table 33 North America: INAAT Market for Hepatitis Diagnosis, By Country, 2017–2024 (USD Million)
Table 34 INAAT Market for Ct/Ng Diagnosis, By Region, 2017–2024 (USD Million)
Table 35 North America: INAAT Market for Ct/Ng Diagnosis, By Country, 2017–2024 (USD Million)
Table 36 INAAT Market for Hiv Diagnosis, By Region, 2017–2024 (USD Million)
Table 37 North America: INAAT Market for Hiv Diagnosis, By Country, 2017–2024 (USD Million)
Table 38 INAAT Market for Influenza Diagnosis, By Region, 2017–2024 (USD Million)
Table 39 North America: INAAT Market for Influenza Diagnosis, By Country, 2017–2024 (USD Million)
Table 40 INAAT Market for Other Infectious Disease Diagnosis, By Region, 2017–2024 (USD Million)
Table 41 North America: INAAT Market for Other Infectious Disease Diagnosis, By Country, 2017–2024 (USD Million)
Table 42 INAAT Market for Blood Screening, By Region, 2017–2024 (USD Million)
Table 43 North America: INAAT Market for Blood Screening, By Country, 2017–2024 (USD Million)
Table 44 Europe: INAAT Market for Blood Screening, By Country, 2017–2024 (USD Million)
Table 45 INAAT Market for Other Applications, By Country, 2017–2024 (USD Million)
Table 46 North America: INAAT Market for Other Applications, By Country, 2017–2024 (USD Million)
Table 47 Europe: INAAT Market for Other Applications, By Country, 2017–2024 (USD Million)
Table 48 Isothermal Nucleic Acid Amplification Technology Market, By End User, 2017–2024 (USD Million)
Table 49 INAAT Market for Hospitals, By Region, 2017–2024 (USD Million)
Table 50 North America: INAAT Market for Hospitals, By Country, 2017–2024 (USD Million)
Table 51 Europe: INAAT Market for Hospitals, By Country, 2017–2024 (USD Million)
Table 52 INAAT Market for Reference Laboratories, By Region, 2017–2024 (USD Million)
Table 53 North America: INAAT Market for Reference Laboratories, By Country, 2017–2024 (USD Million)
Table 54 Europe: INAAT Market for Reference Laboratories, By Country, 2017–2024 (USD Million)
Table 55 INAAT Market for Academic & Research Institutes, By Region, 2017–2024 (USD Million)
Table 56 North America: INAAT Market for Academic & Research Institutes, By Country, 2017–2024 (USD Million)
Table 57 Europe: INAAT Market for Academic & Research Institutes, By Country, 2017–2024 (USD Million)
Table 58 INAAT Market for Other End Users, By Region, 2017–2024 (USD Million)
Table 59 North America: INAAT Market for Other End Users, By Country, 2017–2024 (USD Million)
Table 60 Europe: INAAT Market for Other End Users, By Country, 2017–2024 (USD Million)
Table 61 INAAT Market, By Region, 2017–2024 (USD Million)
Table 62 North America: INAAT Market, By Product, 2017–2024 (USD Million)
Table 63 North America: INAAT Market, By Type, 2017–2024 (USD Million)
Table 64 North America: INAAT Market, By Application, 2017–2024 (USD Million)
Table 65 North America: INAAT Market for Infectious Disease Diagnosis, By Disease Type, 2017–2024 (USD Million)
Table 66 North America: INAAT Market, By End User, 2017–2024 (USD Million)
Table 67 North America: INAAT Market, By Country, 2017–2024 (USD Million)
Table 68 US: INAAT Market, By Product, 2017–2024 (USD Million)
Table 69 US: INAAT Market, By Type, 2017–2024 (USD Million)
Table 70 US: INAAT Market, By Application, 2017–2024 (USD Million)
Table 71 US: INAAT Market for Infectious Disease Diagnosis, By Disease Type, 2017–2024 (USD Million)
Table 72 US: INAAT Market, By End User, 2017–2024 (USD Million)
Table 73 Canada: INAAT Market, By Product, 2017–2024 (USD Million)
Table 74 Canada: INAAT Market, By Type, 2017–2024 (USD Million)
Table 75 Canada: INAAT Market, By Application, 2017–2024 (USD Million)
Table 76 Canada: INAAT Market for Infectious Disease Diagnosis, By Disease Type, 2017–2024 (USD Million)
Table 77 Canada: INAAT Market, By End User, 2017–2024 (USD Million)
Table 78 Europe: INAAT Market, By Product, 2017–2024 (USD Million)
Table 79 Europe: INAAT Market, By Type, 2017–2024 (USD Million)
Table 80 Europe: INAAT Market, By Application, 2017–2024 (USD Million)
Table 81 Europe: INAAT Market for Infectious Disease Diagnosis, By Disease Type, 2017–2024 (USD Million)
Table 82 Europe: INAAT Market, By End User, 2017–2024 (USD Million)
Table 83 Europe: INAAT Market, By Country, 2017–2024 (USD Million)
Table 84 Germany: INAAT Market, By Product, 2017–2024 (USD Million)
Table 85 Germany: INAAT Market, By Type, 2017–2024 (USD Million)
Table 86 Germany: INAAT Market, By Application, 2017–2024 (USD Million)
Table 87 Germany: INAAT Market, By End User, 2017–2024 (USD Million)
Table 88 France: INAAT Market, By Product, 2017–2024 (USD Million)
Table 89 France: INAAT Market, By Type, 2017–2024 (USD Million)
Table 90 France: INAAT Market, By Application, 2017–2024 (USD Million)
Table 91 France: INAAT Market, By End User, 2017–2024 (USD Million)
Table 92 UK: INAAT Market, By Product, 2017–2024 (USD Million)
Table 93 UK: INAAT Market, By Type, 2017–2024 (USD Million)
Table 94 UK: INAAT Market, By Application, 2017–2024 (USD Million)
Table 95 UK: INAAT Market, By End User, 2017–2024 (USD Million)
Table 96 RoE: INAAT Market, By Product, 2017–2024 (USD Million)
Table 97 RoE: INAAT Market, By Type, 2017–2024 (USD Million)
Table 98 RoE: INAAT Market, By Application, 2017–2024 (USD Million)
Table 99 RoE: INAAT Market, By End User, 2017–2024 (USD Million)
Table 100 APAC: INAAT Market, By Product, 2017–2024 (USD Million)
Table 101 APAC: INAAT Market, By Type, 2017–2024 (USD Million)
Table 102 APAC: INAAT Market, By Application, 2017–2024 (USD Million)
Table 103 APAC: INAAT Market for Infectious Disease Diagnosis, By Disease Type, 2017–2024 (USD Million)
Table 104 APAC: INAAT Market, By End User, 2017–2024 (USD Million)
Table 105 RoW: INAAT Market, By Product, 2017–2024 (USD Million)
Table 106 RoW: INAAT Market, By Type, 2017–2024 (USD Million)
Table 107 RoW: INAAT Market, By Application, 2017–2024 (USD Million)
Table 108 RoW: INAAT Market for Infectious Disease Diagnosis, By Disease Type, 2017–2024 (USD Million)
Table 109 RoW: INAAT Market, By End User, 2017–2024 (USD Million)


List of Figures (33 Figures)

Figure 1 Research Design
Figure 2 Breakdown of Primaries: INAAT Market
Figure 3 Market Size Estimation: INAAT Market
Figure 4 Data Triangulation Methodology
Figure 5 Isothermal Nucleic Acid Amplification Technology Market Share, By Product, 2018
Figure 6 Isothermal Nucleic Acid Amplification Technology Market Share, By Application, 2018
Figure 7 Isothermal Nucleic Acid Amplification Technology Market, By Type, 2018
Figure 8 Isothermal Nucleic Acid Amplification Technology Market Share, By End User, 2018
Figure 9 Geographical Snapshot of the Isothermal Nucleic Acid Amplification Technology Market
Figure 10 Rising Prevalence of Infectious Diseases and the Introduction of Newer Pathogens-Key Market Growth Drivers
Figure 11 Assays, Kits, & Reagents to Account for the Largest Share of the North American INAAT Market in 2019
Figure 12 Hospitals to Account for the Largest Market Share in 2019
Figure 13 Infectious Disease Diagnosis to Account for the Largest Market Share During the Forecast Period
Figure 14 Transcription-Mediated Amplification Technology to Account for the Largest Share of the Market in 2019
Figure 15 Geographical Snapshot of the INAAT Market
Figure 16 North America: INAAT Market Snapshot
Figure 17 APAC: INAAT Market Snapshot
Figure 18 Rank of Companies in the Isothermal Nucleic Acid Amplification Technology Market, 2018
Figure 19 Isothermal Nucleic Acid Technology Market (Global) Competitive Leadership Mapping, 2018
Figure 20 Grifols: Company Snapshot (2018)
Figure 21 Hologic, Inc.: Company Snapshot (2018)
Figure 22 Abbott Laboratories, Inc.: Company Snapshot (2018)
Figure 23 Becton, Dickinson and Company: Company Snapshot (2018)
Figure 24 Meridian Bioscience: Company Snapshot (2018)
Figure 25 EIKEN CHEMICALS: Company Snapshot (2018)
Figure 26 Quidel Corporation: Company Snapshot (2018)
Figure 27 Tecan Trading AG: Company Snapshot (2018)
Figure 28 Diasorin: Company Snapshot (2018)
Figure 29 Qiagen: Company Snapshot (2018)
Figure 30 Illumina: Company Snapshot (2018)
Figure 31 Thermo Fisher Scientific: Company Snapshot (2018)
Figure 32 Biomιrieux SA: Company Snapshot (2018)
Figure 33 GE Healthcare: Company Snapshot (2018)

The study involved two major activities in estimating the current size for isothermal nucleic acid amplification technology (INAAT) market. Exhaustive research was conducted to collect information on the market as well as its peer and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and sub-segments.

Secondary Research

In the secondary research process, various sources such as Hoovers, Bloomberg BusinessWeek, Forbes, and Dun & Bradstreet were referred to, to identify and collect information useful for a technical, market-oriented, and commercial study of the INAAT market. These secondary sources include annual reports, press releases & investor presentations of companies, World Health Organization (WHO), European Molecular Biology Organization (EMBO), Association of Medical Diagnostics Manufacturers (AMDM), British In Vitro Diagnostic Association (BIVDA), Centers for Disease Control and Prevention (CDC), National Center for Genome Resources (NCGR), National Institute of Genetics (NIG). Secondary sources also include corporate & regulatory filings (such as annual reports, SEC filings, investor presentations, and financial statements); business magazines & research journals; press releases; and trade, business, and professional associations, among others, ScienceDirect, Annual Reports, Press Releases, Investor Presentations, Expert Interviews, and MarketsandMarkets Analysis. Secondary research was mainly used to obtain vital information about the industry’s supply chain, the total pool of key players, market classification, and segmentation according to industry trends to the bottom-most level and regional markets. It was also used to obtain information about the key developments from a market-oriented perspective.

Primary Research

The INAAT market comprises several stakeholders such as raw material suppliers, manufacturers of INAAT systems, and regulatory organizations in the supply chain. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The primary interviewes from the demand side include key opinion leaders in research personnel in laboratories, academic & research institutes, purchase managers in biotechnology & pharmaceutical companies, and other end users. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing directors, technology and innovation directors, and related key executives from various key companies and organizations operating in the TFF market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information.  Following is the profile breakup of primary respondents:

Isothermal Nucleic Acid Amplification Technologies Market, INAAT Market

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

For the calculation of the global market value, the segmental revenue was arrived at based on revenue mapping of major players active in the INAAT market. This process involved the following steps:

  • Generating a list of the major global players operating in the INAAT market
  • Mapping the annual revenue generated by major global players from the INAAT segment (or the nearest reported business unit/product category)
  • Revenue of top five players to cover at least 85%-90% of the global market share, as of 2018
  • Calculation of 100% global market value of the INAAT based on the 85%-90% revenue share of top five players.

Data Triangulation

After arriving at the overall market size-using the market size estimation processes explained above-the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides of the INAAT market.

Report Objectives

  • To define, describe, and forecast the global INAAT market, by product, type, application, end user, and region
  • To provide detailed information regarding the major factors influencing the growth of the INNAT market (drivers, restraints, and opportunities)
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall INAAT market
  • To analyze opportunities in the market for stakeholders and provide details of a competitive landscape for the market leaders
  • To forecast the size (by value) of market segments with respect to four main regions (along with countries)—North America, Europe, Asia Pacific, and the Rest of the World
  • To profile key players and comprehensively analyze their core competencies in terms of key market developments and growth strategies
  • To track and analyze competitive developments such as product launches, acquisitions, agreements, and  expansions, in the INAAT market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of the top five companies

Geographic Analysis

  • Further breakdown of the Asia Pacific isothermal nucleic acid amplification technology market into India, China, Japan, and the RoAPAC
  • Further breakdown of the RoW isothermal nucleic acid amplification technology market into Latin America and the Middle East & Africa
  • Further breakdown of the European isothermal nucleic acid amplification technology market into  Spain, and Italy

Company Information

  • Detailed analysis and profiling of additional market players (Up to 5)
Report Code
BT 2491
Published ON
Jan, 2020
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Isothermal Nucleic Acid Amplification Technology/INAAT Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home